Method of preparing derivatives of o-(3-amino-2-oxypropyl)amidoxime or their salts

专利摘要:
The compounds of general formula I, wherein R<1> to R<5>, m and n have the meaning given in Claim 1, are valuable medicaments which are suitable for the treatment of diabetic angiopathy. They are prepared by either reacting an amidoxime of formula II with epichlorohydrin to give an epoxide of formula IV and then reacting the epoxide with an amine of formula III or by directly reacting the amidoxime of formula II with a 3-amino-2-hydroxy-1-halogenopropane of formula Va, wherein X represents halogen, or a 3-amino-1,2-epoxypropane of formula Vb. Compounds of formula I, wherein R<1> denotes hydrogen, are also prepared by reacting an amidoxime of formula II with a 2-phenyl-5-halogenomethyloxazolidine of formula VI, wherein X represents halogen, after which the ring compound obtained, of formula VII, is cleaved hydrolytically. <IMAGE>
公开号:SU730296A3
申请号:SU772514754
申请日:1977-08-26
公开日:1980-04-25
发明作者:Такач Кальман；Литерати Надь Петер；Кишш Илона；Шимай Антал；Сентиваньи Матьяш；Вираг Шандор；Фараго Каталин
申请人:Хиноин Дьедьсереш Ведьесети Термекек Дьяра Рт (Инопредприятие)；
IPC主号:

专利说明:

salt is in
that the oxime of the general formula
Vf) (21
fin.
where Rj, R4, Rsr P1 and p have the indicated meanings, are reacted with epichlorohydrin and amine of the general formula
(five)
HN
to,;
de RI and R2 are as defined,
in the presence of a base at minus 10 - plus 140 ° C, followed by isolation of the target product in the free ide or in the form of a salt.
Preferably, the process is carried out in the presence of a solvent such as water, benzene, aliphatic alcohol, acetone.
The amidoximes of general formula 2 are reacted with epichlorohydrin in the presence of a base. The intermediate epoxy compound formed in this case is isolated if desired, but it is preferable not to isolate the intermediate product, but to carry out the reaction in one stage in an aqueous medium in organic solvents, or in aqueous organic solvents, or in two-phase mixtures of solvents at minus 10plus 140 ° C.
Preferably, the amidoxime is dissolved or suspended in an aqueous base and the solution or suspension is shifted with a 1-4 fold molar amount of epichlorohydrin. The addition of epichlorohydrin is carried out with stirring and at minus 10 - plus 140 ° C. Epichlorohydrin is added or added dropwise in several portions. It doesn’t matter what component of the reaction is placed in the flask and the drop is added, the sequence can also be reversed. The intermediate epoxy compound can be isolated by extraction with a water-immiscible solvent. However, it is preferable that the intermediate center not be isolated, but immediately introduced into interaction with the corresponding amine of the general formula 3.
In the case of amidoximes that are poorly soluble: in aqueous alkali, aqueous organic solvents, such as aqueous alcohol or dioxane, can also be used as a solvent. The reaction can also be carried out in the presence of an emulsifier or in a two-phase system. In this case, the epichlorohydrin is dissolved in a non-water-soluble organic builder (for example, in benzene or ether) and the solution is added to the amidoxime solution or suspension prepared in aqueous base. You can also pre-place the Epichlorohydrin solution and add the amidoxime compound.
It is also possible to carry out the process in anhydrous solvents, preferably in anhydrous alcohols, 3 in this case, an alkaline amidoxime salt is preferably formed due to the fact that amidoxime is dissolved in a spit solution of an alkali metal alcoholate. After the addition of epichlorohydrin, the reaction mixture is allowed to stand for 1-5 days at 0-20 ° C, then the appropriate amine is added and the reaction mixture is heated. As an anhydrous solvent, in addition to alcohols, organic solvents such as acetone, dimethyl sulfoxide, dimethylformamide and their mixtures are also used,
Isolation of the reaction products is carried out in the usual manner. When using an aqueous reaction medium, the products are separated by crystallization or extraction. Compounds are crystallized from organic solvents or the solvent is evaporated, the residue is washed and then extracted. Products can also be isolated as their salts, and free bases can be isolated from the salts. From free innovations, by adding 1-2 equivalents of organic or inorganic acid, salt can be obtained. Conventional non-toxic acids are commonly used for salt formation.
Example 1 2.3 g of sodium are dissolved in 200 ml of absolute alcohol and the solution is mixed -13.6 g of benzamidoxime. From 9.3 g of epichlorohydrin and 8.5 g of piperidine, in a known manner, prepared are Z-piperidino-2-hydroxy-1-chloropropane and its solution prepared with 50 ml of absolute alcohol is added dropwise to a solution of the alklate at boiling. The reaction mixture is heated under reflux for 8 hours, then filtered and the solvent is evaporated in vacuo. The residue is mixed with 100 ml of a 5% aqueous solution of sodium hydroxide and the oily product is extracted with benzene. After evaporation of the solvent, 9.2 g of 0- (3-piperidino-2-hydroxy-1-propyl) benzamidoxime, mp. 97 ° C (DI.IEOPROPYL ether). Found,% C 64.69; H 8.46;
N 14.87
S | Nge MzOg (M 277, 35) Calculated,%: C 64.95; H 8.36;
N 15.15.
The product dihydrochloride can be isolated by passing gaseous HCJ. or by means of the addition of alcoholic hydrochloric acid from a prepared isopropanol with a solution of ol, t, pl.212 (isopropanol). Found,%: C1 19.90 С, 5 «25 ззОаС12 (М 50.29) Calculated,%: С1 20.24. The nicotinic acid salt of the product can be obtained in absolute alcohol. It crystallizes upon the addition of gasoline, m.p. 112c (methylethyl Found;%; C 52.84; H 7.11; N 13.76. CQI HIS (M 400 Calculated,%: C 62.98; H 7.05; N 14.00 P and M a p 2. Described in the process in 1 way from 3,4-dimethoxyphedetamidoxime and 3-piperidino-2-hydroxy-1-chloropropane, 0- (3-piperidino-2-hydroxy-1-propyl) -3,4-dimethoxyphenylaceticoids 1 .l1m-di-hydrochloride, mp 202-203C (absolute alcohol). Found: C 50.80; H 7.57; N 9.84; C1 16.42 Ce HSI (M 424.38 ) Calculated,%; C 50.94; H 7.36; H 9.90, C1 16.71. 3. In the manner described in Example Example 1 of 3,4-dchmethoxypheny of acetacidoxime and 3-f1,2,3, 4-tetra po-2-isoxynolyl) -2-hydroxy-1-chlorprop get O-3- (1, 2, 3, 4-tetrahydro-rosoquinolyl) -2-OXI-1-pr opil-3,4-dimethoxyphenylacetamide oxime dihydrochloride, mp 189 ° C (isoprop,%, C, 55.89; H, 6.82; N, 8.64; C1, 14.75 CM HSI N3 0 C Ig (M 472, 40) Calculated,%; C 55.93; H, 6.61; N 8.89, C, 15.01 Example Described in Example 1 in the following way and am - 1-oxime 3, 3-diphenylpropionic acid and -piperidino-2-hydroxy -1-Chl propane, get dihydrochloride amy doxy O- (3-piperidino-2-hydroxy-1-pyl) -3,3-diphenylpropionic acid, so pl. 228-230 ° C (isopropanol). Found,%: C 60.45; H 7.25; N 8.94; C1 15.79. C25 H „NiOjCl (M 454.42) Calculated,%: C 60.79; H 7.32; N 9.25; C1 15.60. Example 5. Described in step 1 from amidoxime of no acid and 3-piperidino-2-hydroxy-chloropropane, O- (3-piperidino-2-hydroxy -1-propyl) nicotinic acid dihydrochloride amidoxime is obtained, v. 204C (absolute alcohol). C 47.59; H 7.00; Found,%: N 1-5,64, С1 19.89 С «Нй4, (М 351.27) Calculated,%: С 47.87; H 6.89; N 15.95; -Cl 20.19. Nicotinate salt can be crystallized from ethyladetate, t, p. (ethyl acetate). Found,%: C 59.80; H 6.92; N 17.2: СGO Н27 N504 (М 401.46) Klisleko,%: C 59.83; H 6.77; N 17.44. Example 6, 10.45 g of 3,4-dimethoxyphenylacetamide oxime was dissolved with 40 kp of 10% sodium hydroxide solution when heated. This solution is heated at room temperature and, while stirring, is added to 17.8 g of 3-piperidino-3-hydroxy-1-chloropropane dropwise over half an hour. Then, the reaction mixture is perenlivated at room temperature for 8 hours and left for night. The oily product is extracted with benzene, the extract is dried over sodium sulfate and the solvent is evaporated. The residue after evaporation is dissolved in β-ethyl acetate. Passing gaseous HC), 10.5 g of O- (3-piperidino-2-hydroxy-1-propnl) -3, 4-dimethoxyphenyl acetate-alvIvidoxo-dihydrochloride crystallized into this solution. The product is identical to the product of example 2, t, pl „201-203®С. Example 7. 5.2 g of 3,4-dimethoxyphenylacetamide oxma is dissolved by heating in 40 ml of 10% sodium hydroxide solution. The solution for half an hour at room temperature added to a solution of 8.8 g of 3-piperidino-2-OXI-1-chloropropane in 20 ml of benzene. The mixture was kept stirring at room temperature for 8 hours and then left overnight. The benzene phase is then separated. The aqueous phase is extracted with benzol. The combined benzene phases are dried over sodium sulfate, then the solvent is evaporated, and the hydrochloric acid salt is obtained after the residue as described in Example 6. The obtained O- (3-piperidino-2-hydroxy-1-propyl) -3, 4-dimethoxyphenylacetamidoxime is identical to the product of example 2, Example 8. 5.2 g3, 4 dimethoxyphenylacetamide oxime is dissolved in a mixture of 40 ml of 10% sodium hydroxide solution and 40 ml mp methanol. The solution, while stirring for half an hour, is added dropwise to 8.8 g of 3-piperidino-2-hydroxy-1-chloropropane. The mixture was stirred at room temperature for 8 hours and then left overnight. Methanol is evaporated. The residue as described in Example 7 is treated by extraction with benzene and salt formation. The obtained 0- {3-piperidino-2-hydroxy-1-propyl) .- 3, 4 dimethoxy-phenylamine amidoxime-dihydrochloride is identical to the product of example 2.
Example 9. To 2.72 g of benzamidoxime, 40, ml of benzene and 0.8 g of a powdered state of solid sodium hydroxide, are crushed. The reaction mixture is boiled for 1 h in the presence of a water separating nozzle, and during this process a solution of 4, 5-g of 3-pyridin-2-oxy-1-chloropropane in 10 ml of benzene is added dropwise. After boiling for 12 hours, the solvent is evaporated, the residue is dissolved in 20 ml of a 10% sodium hydroxide solution. The oily product is extracted with benzene. After evaporation of the benzene, 3.6 g of 0- (3-piperidino-2-oxy-1-propyl) benzamidoxime is obtained, which is identical to the product obtained in Example 1.
Example 10. To a solution of ethylate prepared from 2.3 g of sodium and 200 ml of absolute alcohol, 15.5 g of 4-chlorobenzamidoxime was added. 9.3 g of epichlorohydrin are added dropwise to the mixture. The mixture was stirred at 0-10 ° C for 8 hours and then left overnight at the same temperature. The precipitated sodium chloride is filtered off, 8.6 g of piperidine is added dropwise to the filtrate with stirring. The mixture is stirred at room temperature for 8 hours, then heated to boiling and the solvent is removed in vacuo. The residue is mixed with 50 ml of a 5% sodium hydroxide solution and the oily substance is extracted with benzene. The benzene extract is dried over sodium sulfate, then evaporated and the residue is dissolved in absolute alcohol. After passing gaseous HC1 or by adding hydrochloric alcohol, 11.0 g of 0-3-piperidino-2-hydroxy-1-propyl) -4-chlorobenzamidoxime-dihydrochloride are obtained, m.p. 215217 ° C (absolute alcohol).
Found,%: C 46.57; H 6.41; N 10.58 С | 5 Nm NsOaCla (M 384.73)
Calculated,%: C 46.83; H 6.29; N 10.92
Example 11. From phenylacetamidoxime and diethylamine as described in Example 10, 0- (3-diethylamino-2-hydroxy-1-propyl) phenyl-schistamidoxime-dihydrochloride, m.p. 156-1 ° C (isopropanol).
Found,%: C 50.89; H 7.65
N 11.83, C1 20.10
Cib H27 NjOjCla (M 352.30) Calculated,%: C 51.14; H 7.73;
N 11, 93, C1 20.12.
Example 12. From phenylacetamidoxime and piperidine as described in example 10, 0- (3-piperidino-2-hydroxy-1-propyl) phenylacetamidoxime-dihydrochloride is obtained, m.p. 198-20os (absolute alcohol).
Found: C, 52.40; H 7.51; N 11.20, C1 19.85
Ci6 H27 5 (M 364.31)
Calculated,%: C 52.75; H 7.47;
N 11.54; C1 19.47.
Example 13. From 4-chlorophenylacetamidoxime and morpholine described by Q in example 10, 0- (3-MORFOLIN-2-OXY-1-propyl) -4-chlorophenylacetamidoximide-dihydrochloride, mp 175-178 ° C (absolute alcohol) is obtained. Found,%: C 45.20; H 6.10; N 10.52, C1 26.50 CI5 H24 N OjClj (M 400.73) Calculated,% C 44.96; H 6.04;
N 10.48; C1 26.54. Example 14. From amidoxime 0 of 3,3-diphenylpropionic acid and isopropylamine as described in example 10, amidoximes of 0- (3-isopropylamino-2-hydroxy-1-propyl) -3,3-diphenylpropio5 novol acid, m.p. 179 ° C (a mixture of acetone and water).
Found,%: C 58.58; H 7.39; N 9.53, C1 17.70. C2I Hji NjOzClg 0 (M 428.39)
Calculated,%: C 58.87; H 7.29; N 9.81 C1 16.55
Example 15. From amidoxime with 3,3-diphenylpropionic acid and diethylamine in the manner described in example 10, O- (3-diethylamino-2-hydroxy-1-propyl) -3,3-diphenylpropionic acid amidoxime was obtained, mp, 225C (isopropanol). 0 Found,%: C 59.68; H 7.55;
C1 16.07
Crg Nzz NgOgCi
(M 442.42)
Calculated,%: C 59.72; H 7.52; ZC1 16.03.
Example 16. From the amidoxime of 3,3-diphenylpropionic acid and 2-methylaminoethanol, amidoxime O-3-N-methyl0 C2-hydroxyethylamino-2-hydroxy-1-propyl-3, 3-diphenylpropionic acid, mp, is obtained (isopropyl ol ).
Found,%: With 56,40; H 7.09; N 9, 1 4, C 1 1 5, 9 2
5С21 Н31 NjOzCls
Calculated,%: C 56.78; H 7.03;
N 9.45, C1 15.96. Example 17. From the amidoxime of 3,3-diphenylpropionic acid and pyrrolidone described in Example 0 10, an amidoxime O- (3-pyrrolidino-2-hydroxy-1-propyl) -3,3-diphenylpropionic acid dihydrochloride, m.p. 218C (isopropanol).
Found,%: C 59.63; H 7.32; 5С1 16.4 4 Cjj Hz1 NiOgCl (M 440.40) Calculated,%; C, 59.99; H 7.10; C1 16.10. Example 18. From the amidoxime of 3,3-diphenylpropionic acid and piperidine as described in example 10, dihydrochloride is obtained. doxyma O- (3-piperidino-2-hydroxy-1-napyl) -3,3-diphenylpropionic acid The product is identical to the product of example 4 and after recrystallization from isopropanol it melts at 228-2PO. In the course of re 10, dihydrochloride of amidoxime O- (3-heptamethyleneamino-2-hydroxy-1-propyl) -3,3-dipheny propionic acid is obtained, which after crystallization from isopropanol plits at 233 ° C. Found,%: C 61.94; H 7.70; C1. 14.74. C25H3 (M 482.48) C 62.24; H 7.73; Calculated,%: C1 14.70, Example 20. From the amidoxime of 3,3-diphenylpropionic acid and morpholine as described in Example 10, the amidoxime O- (3-morpholin-2 hydroxy-1-propyl) -3,3-diphenylpropionic hydrochloride is obtained , acid, which, after recrystallization from isopropanol, melts t at 225 ° C. Found,%: C 57.66; H 7.13; N 8.95, C1 15.15 C22 Hz1 NjOsCl (M 456.40) C 57.89; H 6.85; N Calculated,%: C1 15.53 21. From 1-naphthyl Example of amidoxime and diethylamine described in example 10 is obtained from O- (3-diethylamino-2-hydroxy-1-propyl) naphthylacetamide oxime, which melts at 150-152 ° C after recrystallization from absolute alcohol. From C, 62.07; H 8.00; N 11.29, C1 9.63 CiQHjeNjOjCl (M 365.89) Calculated,%: C 62.36; H 7.71; N 11.49, C1 9.69 22. From 1-naphthyl Example of acetamidoxime and piperidine as described in example 10, O- (3-piperidIN-2-OXY-1-propyl) -1-naphthylacetamide oxime-hydrochloride is obtained which after recrystallization from absolute alcohol melts pr 177-179 ° C. Found,%: C 63.58; H 7.59; N 11.47 C1 9.60. C2H28 NaOaCl (M-377.89) Vych-yoleene,%: C 63.57; H 7, N 11.12, C1 9.38 Example 23. To a mixture of 4.0 g of benzamidoxime, 10 ml of water and 4.5 g of epichlorohydrin, 20 ml of 10% - are added at room temperature with stirring over 1 hour. solution of caustic soda. The mixture is stirred for another 2 hours, the mixture is mixed with 4.5 g of piperidine and stirred again for 8 hours. After this, the oily compound is extracted with benzene. After evaporation of the benzene solution, 6.2 g of O- (3-piperi-2-o to si-1-propyl) benzamidoxime are obtained, which is identical to that of 5y in the example product. Example 24. 6.8 g of benzamidoxime are dissolved in 40 liters of 10% sodium hydroxide solution and 9.5 g of epichlorohydrin are added to the solution with stirring. The reaction is exothermic, therefore, the temperature is maintained at ZO-BZ C by external oxJ. The mixture is stirred for 2 hours, then 8.6g of piperidine is added dropwise. After further two hours of stirring, the oily product is extracted with benzene. After evaporation of the benzene, 8.2 g of O- (3-piperidino-2-hydroxy-1-propyl) benzamidoxime are obtained. The product is identical to the product of example 1. Example 25. 6.8 g of benzamidoxime are dissolved in 40 ml of 10% sodium hydroxide solution. To the solution with vigorous stirring, 9.5 g of epichlorohydrin in 20 ml of benzene are added dropwise. The mixture is stirred for 4 hours, then mixed with 8.6 g of piperidine and stirred at room temperature for another 8 hours. Then the benzene phase is separated and the aqueous phase is extracted with benzene. The combined benzene solutions are evaporated. O- (3-piperidino-2-hydroxy-1-proO | T; 1 l) bequamidoxime, which is identical to the product obtained in Example 1, is obtained. Example 26.6.8 g of benzamidoxime is dissolved in a mixture of 20 ml of 10% sodium hydroxide and 20 ml of methanol. While stirring, 9.5 g of epichlorohydrin is added dropwise. The mixture is then stirred at room temperature for 2 hours and then mixed with 8.6 g of piperidine. The mixture was stirred for the next 8 hours. The methanol was then removed in vacuo, and the oily residue was extracted with benzene. After evaporation of benzene, 7.2 g of O- (3-piperidino-2-hydroxy-1-propyl) benzamidoxime are obtained, which is identical to the product obtained in Example 1, Example 27. To a solution of 5.2 g of 3, 4-dimethoxyphenylacetamide oxime in 20 ml of dimethyl sulfoxide

权利要求:
Claims (2)
[1]
Claim
1. The method of obtaining derivatives of 0- (3-amino-2-hydroxypropyl) amidoxime of the General formula
K1 x ~ CH ₇ -CH-CH, -C / 1
1 ^g where is he ! and in
10 bottom view
[2]
2. The method of pop. 1, characterized in that the process is carried out in the presence of a solvent, such as Veda, benzene, aliphatic alcohol, acetone.
Featured Priorities
08.27.76 - the target product is isolated in salt form using an inorganic acid;
the desired product is isolated in the form of a salt using an Organic acid.

类似技术:

---

公开号 | 公开日 | 专利标题

---

SU730296A3|1980-04-25|Method of preparing derivatives of o-|amidoxime or their salts

---

US6015903A|2000-01-18|Method of resolving racemic mixtures

---

SU509231A3|1976-03-30|Method for producing morpholine derivatives

---

CA2054544A1|1992-05-01|Process for the preparation of piperazine derivatives

---

SU718009A3|1980-02-25|Method of producing 1-nitro-9-alkylaminoalkylaminoacridines or salts thereof

---

SU448639A3|1974-10-30|The method of obtaining amino-alcohol derivatives of o-trans-hydroxycinnamic acid

---

GB2067215A|1981-07-22|Xanthene compounds

---

IE50061B1|1986-02-05|1-|pyrrolidine derivatives and process for their preparation

---

US2628973A|1953-02-17|Aryloxyacetates of basically substituted arylakanols and derivatives thereof

---

US4305887A|1981-12-15|Process for obtaining the enantiomeric forms of 4-cyano-1-[N-methyl-N-|-amino]-5-methyl-4-|-hexane and of salts thereof

---

US2856427A|1958-10-14|Substituted glycinamides

---

HU193785B|1987-11-30|Process for producing dihydropyridine derivatives

---

SU795487A3|1981-01-07|Method of preparing hellebrigenic derivatives or their salts

---

US3337546A|1967-08-22|Certain 1, 3 oxazines and a process for their preparation

---

SU507241A3|1976-03-15|The method of obtaining derivatives of theophylline

---

SU701531A3|1979-11-30|Method of preparing oxime derivatives or their salts

---

SU625600A3|1978-09-25|Method of producing substituted acetamides or their salts

---

SE415970B|1980-11-17|NEW PROCEDURE FOR THE PREPARATION OF N- | - | -AMINE

---

SU528035A3|1976-09-05|The method of obtaining derivatives of isoquinoline or their salts

---

US3549703A|1970-12-22|Process for making n-|-n-methylhydrocarbon sulfonamides

---

US2814626A|1957-11-26|Oxazolines

---

SU549076A3|1977-02-28|The method of obtaining aminoethanol or their salts

---

KR101974388B1|2019-05-02|Alkyl diethylene triamine derivatives and a process of the preparation thereof

---

SU465786A3|1975-03-30|Method for preparing 4-chloro-m-toluene or 3,4-dichlorobenzenesulfonic acid and -propoxyphene salt

---

US2517496A|1950-08-01|Preparation of symmetrical monoaminodihydroxytoluene

同族专利:

---

公开号 | 公开日

---

BE858134A|1977-12-16|

---

AU2825477A|1979-03-01|

---

NO144793B|1981-08-03|

---

AT355554B|1980-03-10|

---

CS204008B2|1981-03-31|

---

JPS5350131A|1978-05-08|

---

FI68396C|1985-09-10|

---

YU202377A|1983-12-31|

---

IL52804A|1981-06-29|

---

GR63623B|1979-11-27|

---

SE435280B|1984-09-17|

---

PL107628B1|1980-02-29|

---

FI772551A|1978-02-28|

---

FR2362845B1|1981-01-09|

---

NL187478C|1991-10-16|

---

HU177578B|1981-11-28|

---

DK379777A|1978-02-28|

---

CH630344A5|1982-06-15|

---

IL52804D0|1977-10-31|

---

NL7709276A|1978-03-01|

---

NO772958L|1978-02-28|

---

DE2738589A1|1978-03-02|

---

NO144793C|1981-11-11|

---

SE7709482L|1978-02-28|

---

GB1582029A|1980-12-31|

---

YU237782A|1983-12-31|

---

FI68396B|1985-05-31|

---

AU521432B2|1982-04-01|

---

ATA605477A|1979-08-15|

---

ES462346A1|1978-06-16|

---

DK150196B|1987-01-05|

---

DD132433A5|1978-09-27|

---

JPS6216942B2|1987-04-15|

---

FR2362845A1|1978-03-24|

---

DK150196C|1987-07-06|

---

CA1077506A|1980-05-13|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US5212314A|1983-11-03|1993-05-18|Merrell Dow Pharmaceuticals Inc.|Alkoxyimino ether derivatives of 5-acyl-2-pyridinones|

---

US4849522A|1983-11-03|1989-07-18|Merrell Dow Pharmaceuticals|Novel alkoxyimino ether derivatives of 5-acyl-2-pyridinones|

---

ZA848428B|1983-11-03|1985-06-26|Merrell Pharma Inc|Novel alkoxyimino ether derivatives of 5-acyl-2-pyridiones|

---

JPH01169445A|1987-12-25|1989-07-04|Fuji Photo Film Co Ltd|Focal distance switching camera|

---

HU207988B|1988-10-20|1993-07-28|Biorex Kutato Fejlesztoe Kft|Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components|

---

HUT54347A|1989-01-10|1991-02-28|Chinoin Gyogyszer Es Vegyeszet|Improved process for producing amidoximes|

---

HU222994B1|1995-11-02|2004-01-28|BIOREX Kutató és Fejlesztő Rt.|Hydroxylamine derivatives and use thereof in the preparation of a pharmaceutical compositions for enhancing of molecular chaperon production of cells|

---

HUT78139A|1995-12-22|2000-11-28|BIOREX Kutató és Fejlesztő Rt.|Composition for reducing skin state aging|

---

RU2213738C2|1998-05-11|2003-10-10|Такеда Кемикал Индастриз, Лтд.|Derivatives of hydroxyiminoalkanoic acid, pharmaceutical composition and agent for regulation of retinoid receptors|

---

WO2000007580A2|1998-08-03|2000-02-17|N-Gene Kutató Kft.|Pharmaceutical compositions against autoimmune diseases|

---

KR20040089102A|2002-01-11|2004-10-20|비오렉스 쿠타토 에쉬 훼레스테 에르테|Carboxamidine derivatives and their use in the treatment of vascular diseases|

---

HU0303584A3|2003-10-30|2009-12-28|Cytrx Corp|Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

HU76CI1682A|HU177578B|1976-08-27|1976-08-27|Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives|

---